Amedisys, Inc. (AMED)

1 member of Congress has disclosed 2 trades in Amedisys, Inc. (AMED) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 18 August 2025. Aggregate disclosed activity totals roughly $8K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for AMED
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for AMED

2 transactions
Compliance: 50%
Lisa McClain18 Aug 202512 Sept 2025SaleStock$1,001 - $15,000N/A
Lisa McClain9 Jun 202513 Aug 2025PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$3.32B

Volume

1.04M

Beta

0.90

P/E Ratio

39.30

Fundamentals

EPS

$2.57

Div. Yield

-

Open

$101.00

Day Range

$100.93 – $101.02

Company Information

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ · USD
Country
US
CEO
Richard M. Ashworth
IPO Date
1994-08-17

Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. Th...

Earnings

Recent Quarters

Q2 202529 Jul
EPS$1.54
Beat 10.8%
Q1 202523 Apr
EPS$1.25
Beat 10.6%
Q4 202426 Feb
EPS$0.96
Miss 8.6%
Q3 20246 Nov
EPS$1.00
Miss 14.5%
Q2 202424 Jul
EPS$1.32
Beat 8.2%
Q1 202424 Apr
EPS$1.03
Beat 2.0%
Q4 202321 Feb
EPS$0.94
Miss 8.7%
Q3 202324 Oct
EPS$0.98
Miss 9.3%
Q2 202326 Jul
EPS$1.37
Beat 28.0%
Q1 20233 May
EPS$1.00
Beat 13.6%
Q4 202215 Feb
EPS$1.16
Beat 16.0%
Q3 202226 Oct
EPS$1.15
Miss 7.3%
Q2 202227 Jul
EPS$1.47
Beat 19.5%
Q1 202227 Apr
EPS$1.23
Beat 9.8%
Q4 202123 Feb
EPS$1.18
Beat 0.0%
Q3 20212 Nov
EPS$1.53
Beat 11.7%
Q2 20214 Aug
EPS$1.69
Beat 3.0%
Q1 202128 Apr
EPS$1.54
Beat 7.7%
Q4 202024 Feb
EPS$1.49
Beat 1.4%
Q3 202028 Oct
EPS$2.24
Beat 76.4%
Q2 202028 Jul
EPS$1.34
Beat 65.4%
Q1 20206 May
EPS$1.05
Beat 8.3%
Q4 201918 Feb
EPS$0.94
Beat 1.1%
Q3 201929 Oct
EPS$1.15
Beat 27.8%
Q2 201931 Jul
EPS$1.21
Beat 22.2%
Q1 201930 Apr
EPS$1.11
Beat 23.3%
Q4 201827 Feb
EPS$0.91
Beat 7.1%
Q3 201829 Oct
EPS$0.95
Beat 23.4%
Q2 201831 Jul
EPS$1.00
Beat 28.2%
Q1 20187 May
EPS$0.79
Beat 17.9%
Q4 201727 Feb
EPS$0.56
Miss 5.1%
Q3 20177 Nov
EPS$0.56
Beat 3.7%
Q2 201726 Jul
EPS$0.62
Beat 24.0%
Q1 20172 May
EPS$0.47
Beat 14.6%
Q4 201628 Feb
EPS$0.44
Beat 10.0%
Q3 20163 Nov
EPS$0.36
Miss 14.3%
Q2 20162 Aug
EPS$0.42
Beat 2.4%
Q1 20163 May
EPS$0.33
Miss 2.9%
Q4 20158 Mar
EPS$0.40
Beat 14.3%
Q3 20155 Nov
EPS$0.34
Beat 0.0%
Q2 201529 Jul
EPS$0.43
Beat 26.5%
Q1 201529 Apr
EPS$0.30
Beat 50.0%
Q4 20144 Mar
EPS$0.27
Beat 3.9%
Q3 201429 Oct
EPS$0.28
Beat 86.7%
Q2 201430 Jul
EPS$0.25
Beat 575.7%
Q1 20148 May
EPS$-0.07
Miss 16.7%
Q4 201312 Mar
EPS$-0.05
Miss 313.6%
Q3 201312 Nov
EPS$-0.01
Miss 107.7%
Q2 201331 Jul
EPS$0.17
Beat 70.0%
Q1 201330 Apr
EPS$0.13
Miss 38.1%
Q4 201212 Mar
EPS$0.23
Beat 4.5%
Q3 20126 Nov
EPS$0.33
Beat 22.2%
Q2 20127 Aug
EPS$0.27
Beat 12.5%
Q1 20128 May
EPS$0.22
Beat 0.0%
Q4 201128 Feb
EPS$0.49
Beat 75.0%
Q3 20111 Nov
EPS$0.36
Miss 28.0%
Q2 20112 Aug
EPS$0.67
Miss 1.5%
Q1 201126 Apr
EPS$0.62
Miss 4.6%
Q4 201022 Feb
EPS$0.95
Beat 4.4%
Q3 201026 Oct
EPS$0.89
Miss 2.2%
Q2 20109 Aug
EPS$1.16
Beat 0.9%
Q1 201027 Apr
EPS$1.29
Beat 0.8%
Q4 200923 Feb
EPS$1.35
Beat 3.0%
Q3 200927 Oct
EPS$1.29
Beat 1.6%
Q2 200928 Jul
EPS$1.27
Beat 24.5%
Q1 200928 Apr
EPS$0.99
Beat 2.1%
Q4 200817 Feb
EPS$0.98
Beat 7.7%
Q3 200828 Oct
EPS$0.89
Beat 8.5%
Q2 200829 Jul
EPS$0.82
Beat 18.8%
Q1 200830 Apr
EPS$0.62
Beat 6.9%
Q4 200727 Feb
EPS$0.63
Beat 5.0%
Q3 200730 Oct
EPS$0.61
Beat 8.9%
Q2 200731 Jul
EPS$0.57
Beat 7.5%
Q1 20071 May
EPS$0.51
Beat 2.0%
Q4 200620 Feb
EPS$0.48
Miss 2.0%
Q3 200625 Oct
EPS$0.48
Beat 6.7%
Q2 20061 Aug
EPS$0.41
Beat 5.1%
Q1 20062 May
EPS$0.34
Miss 2.9%
Q4 200522 Feb
EPS$0.34
Miss 17.1%
Q3 20051 Nov
EPS$0.39
Beat 5.4%
Q2 20052 Aug
EPS$0.38
Beat 15.2%
Q1 20053 May
EPS$0.34
Beat 13.3%
Q4 200410 Mar
EPS$0.29
Beat 7.4%
Q3 20043 Nov
EPS$0.29
Beat 7.4%
Q2 20043 Aug
EPS$0.29
Beat 20.8%
Q1 20044 May
EPS$0.26
Beat 23.8%
Q4 20039 Mar
EPS$0.23
Beat 35.3%
Q3 20035 Nov
EPS$0.17
Beat 30.8%
Q2 200312 Aug
EPS$0.12
Beat 33.3%
Q1 200313 May
EPS$0.09
Beat 12.5%
Q4 200213 Mar
EPS$0.08
Beat 0.0%
Q3 200211 Nov
EPS$0.10
Beat 25.0%
Q2 200214 Aug
EPS$0.14
Q2 20027 Aug
EPS$0.13
Miss 18.8%
Q4 200121 Mar
EPS$0.24
Q3 200114 Nov
EPS$0.19
Q2 200120 Aug
EPS$0.12
Q1 200114 May
EPS$0.22
Q4 200019 Mar
EPS$0.97
Q3 200014 Nov
EPS$-0.12
Q2 200021 Aug
EPS$-0.26
Q1 200015 May
EPS$-0.30
Q4 199930 Mar
EPS$-0.21
Q3 199915 Nov
EPS$1.48
Q2 199916 Aug
EPS$-0.36
Q1 199917 May
EPS$-0.61
Q4 199831 Mar
EPS$-3.98
Q3 199820 Nov
EPS$-0.98
Q2 199814 Aug
EPS$-0.62
Q1 199822 May
EPS$-0.83
Q1 199816 Apr
EPS$-0.70
Q3 199714 Nov
EPS$0.08
Q2 199714 Aug
EPS$0.12
Q1 199715 May
EPS$0.12
Q1 199714 Apr
EPS$-0.19
Q3 199614 Nov
EPS$0.04
Q2 199614 Aug
EPS$0.10
Q1 199621 May
EPS$0.08
Q3 199531 Dec
EPS$0.04
Q2 199530 Sept
EPS$0.10
Q1 199530 Jun
EPS$0.08
Q4 199431 Mar
EPS$0.06
Q3 199431 Dec
EPS$0.73
Q2 199430 Sept
EPS$-0.01
Q1 199430 Jun
EPS$0.02
Q4 199331 Mar
EPS$0.01
Q3 199331 Dec
EPS$-0.16
Q2 199330 Sept
EPS$-0.08
Q1 199330 Jun
EPS$0.04
Q4 199231 Mar
EPS$0.07

No dividend data available for this stock.

Stock Splits

Split History

5 Dec 2006Stock Split
Ratio4:3

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about AMED

Which members of Congress have traded AMED?
1 member of Congress has disclosed 2 trade in Amedisys, Inc. (AMED) under the STOCK Act: Lisa McClain.
When was AMED most recently disclosed by Congress?
The most recent AMED disclosure was a sale by Lisa McClain on 18 August 2025.
What is the total disclosed congressional trading volume for AMED?
Members of Congress have disclosed approximately $8K in AMED purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in AMED?
This AMED page updates as soon as new STOCK Act disclosures are filed for Amedisys, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.